North America Heart Transplant Market Forecast to 2030 - Regional Analysis

List of Tables

The North America heart transplant market is expected to grow from US$ 7,252.10 million in 2022 to US$ 17,192.72 million by 2030. It is estimated to grow at a CAGR of 11.4% from 2022 to 2030.

Use of AI in Transplantation Procedures Fuels North America Heart Transplant Market

A uniquely designed system backed by artificial intelligence (AI) facilitates the detection of early signs and seriousness of the host rejection post-heart transplantation. The endomyocardial biopsy (EMB) screening signifies the standard of care for identifying allograft rejections after a heart transplant. In 2022, a new AI system was designed known as the Cardiac Rejection Assessment Neural Estimator (CRANE), which can be used in tandem with medical assessments for rapid and precise diagnosis. CRANE also helps reduce differences regarding the presence and severity of heart rejection in the host body. It is a deep learning-based AI system for the automated assessment of gigapixel whole-slide images obtained from EMBs. In 2020, the National Institute of Health granted US$ 3.2 million to studies based on the exploration of the capabilities of AI in heart transplants. With this grant, researchers from Perelman School of Medicine (the University of Pennsylvania), Case Western Reserve University, Cleveland Clinic, and Cedars-Sinai Medical Center aimed to study what causes the rejection of a new heart and how to manage it. They used AI to analyze cardiac biopsy tissue images, finding the types of immune cells that play an instrumental role in new heart rejection. Thus, the adoption of AI in heart transplantation procedures is likely to bring new trends in the market in the coming years.

North America Heart Transplant Market Overview

The heart transplant market in North America is segmented into the US, Canada, and Mexico. North America accounted for the largest market share in 2022, and the market growth can be attributed to an upsurge in the geriatric population, the prevalence of cardiovascular diseases, and an increase in heart failure cases. The increasing incidences of chronic kidney diseases and the rising geriatric population are the key factors contributing to the heart transplant market growth in the US. According to data provided by the American Heart Association Inc., ~1 million new heart failure cases are registered annually in the US, and more than 8 million people are estimated to suffer from heart failure by 2030. As per the Health Research Funding Organization, ~555,000 people were diagnosed with the beginning stages of heart failure in the US in 2021. Cardiovascular diseases (CVDs) generally lead to heart failure or terminal heart disease, which bolsters the demand for heart transplants.

The US Food and Drug Administration (FDA) is increasingly approving various heart transplant procedures and products. In addition, the presence of major companies benefits the market in this country. In April 2022, TransMedics Group, Inc. received premarket FDA approval for its OCS Heart.

North America Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)

North America Heart Transplant Market Segmentation

The North America heart transplant market is segmented into surgery type, type, end user, and country.

Based on surgery type, the North America heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplantation segment held a larger share of the North America heart transplant market in 2022.

In terms of type, the North America heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held a larger share of the North America heart transplant market in 2022. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.

Based on end user, the North America heart transplant market is segmented into hospitals, cardiac centers, and others. The hospitals segment held the largest share of the North America heart transplant market in 2022.

Based on country, the North America heart transplant market is segmented into the US, Canada, and Mexico. The US dominated the North America heart transplant market in 2022.

Terumo Corp, Evaheart Inc, Abbott Laboratories, SynCardia Systems LLC, BiVACOR Inc, BioVentrix Inc, Berlin Heart GmbH, LivaNova Plc, Jarvik Heart Inc, and Calon Cardio-Technology Ltd are some of the leading companies operating in the North America heart transplant market.

Product Code: BMIRE00030077

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Heart Transplant Market - Key Industry Dynamics

4.1 Heart Transplant Market - Key Industry Dynamics
4.2 Market Drivers
- 4.2.1 Increasing Target Disease Incidence
- 4.2.2 Growing Geriatric Population
4.3 Market Restraints
- 4.3.1 High Cost of Surgeries
4.4 Market Opportunities
- 4.4.1 Ongoing Research and Development
4.5 Future Trends
- 4.5.1 Use of AI in Transplantation Procedures
4.6 Impact of Drivers and Restraints:

5. Heart Transplant Market - North America Market Analysis

5.1 Heart Transplant Market Revenue (US$ Million), 2020 - 2030
5.2 Heart Transplant Market Forecast and Analysis

6. North America Heart Transplant Market Analysis - Surgery Type

6.1 Overview
6.2 Orthotopic Heart Transplant
- 6.2.1 Overview
- 6.2.2 Orthotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Heterotopic Heart Transplant
- 6.3.1 Overview
- 6.3.2 Heterotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)

7. North America Heart Transplant Market Analysis - Type

7.1 Overview
7.2 Donor Live Heart
- 7.2.1 Overview
- 7.2.2 Donor Live Heart Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Artificial Hearts
- 7.3.1 Overview
- 7.3.2 Artificial Hearts Market, Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Ventricular Assisted Device
    - 7.3.2.1.1 Ventricular Assisted Device Market, Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.2 Total Artificial Heart
    - 7.3.2.2.1 Total Artificial Heart Market, Revenue and Forecast to 2030 (US$ Million)

8. North America Heart Transplant Market Analysis - End User

8.1 Overview
8.2 Hospitals
- 8.2.1 Overview
- 8.2.2 Hospitals Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Cardiac Centers
- 8.3.1 Overview
- 8.3.2 Cardiac Centers Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. North America Heart Transplant Market - Country Analysis

9.1 North America
- 9.1.1 North American Transplant Market Overview
- 9.1.2 North America Heart Transplant Market Breakdown by Country (2022 and 2030)
  - 9.1.2.1 US: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.1.1 Overview
    - 9.1.2.1.2 United States Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 9.1.2.1.3 United States Heart Transplant Market Breakdown by Surgery Type
    - 9.1.2.1.4 United States Heart Transplant Market Breakdown by Type
    - 9.1.2.1.4.1 United States Heart Transplant Market Breakdown by Artificial Hearts
    - 9.1.2.1.5 United States Heart Transplant Market Breakdown by End User
  - 9.1.2.2 Canada: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.2.1 Overview
    - 9.1.2.2.2 Canada Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 9.1.2.2.3 Canada Heart Transplant Market Breakdown by Surgery Type
    - 9.1.2.2.4 Canada Heart Transplant Market Breakdown by Type
    - 9.1.2.2.4.1 Canada Heart Transplant Market Breakdown by Artificial Hearts
    - 9.1.2.2.5 Canada Heart Transplant Market Breakdown by End User
  - 9.1.2.3 Mexico: Heart Transplant Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.3.1 Overview
    - 9.1.2.3.2 Mexico Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
    - 9.1.2.3.3 Mexico Heart Transplant Market Breakdown by Surgery Type
    - 9.1.2.3.4 Mexico Heart Transplant Market Breakdown by Type
    - 9.1.2.3.4.1 Mexico Heart Transplant Market Breakdown by Artificial Hearts
    - 9.1.2.3.5 Mexico Heart Transplant Market Breakdown by End User

10. Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Heart Transplant Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Terumo Corp
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Evaheart Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abbott Laboratories
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 SynCardia Systems LLC
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 BiVACOR Inc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 BioVentrix Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Berlin Heart GmbH
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 LivaNova Plc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Jarvik Heart Inc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments

12. Appendix

12.1 About the Insight Partners